2000
DOI: 10.1007/s100380070004
|View full text |Cite
|
Sign up to set email alerts
|

Two pathogenic point mutations exist in the authentic mitochondrial genome, not in the nuclear pseudogene

Abstract: Technical advancements in molecular genetics have shown various mitochondrial DNA (mtDNA) abnormalities in patients with mitochondrial myopathies. Recently, it has been revealed that, in these patients, the nuclear DNA carries sequences similar to those of the mtDNA (nuclear pseudogene) and it has several point mutations previously reported to be pathogenic. We verified the existence of the T3250C and T3291C mutations, which we have found in patients with mitochondrial myopathy, in the authentic mitochondrial … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(18 citation statements)
references
References 15 publications
0
18
0
Order By: Relevance
“…18 For mutation analysis, first, the DNA samples were analyzed for the presence of large deletions and five common point mutations (A3243G, T3271C, A8344G, T8993G and T8993C) by southern blot/long-range PCR and PCR-restriction fragment-length polymorphism, respectively, according to published procedures. 15,19 Second, for those patients without common mutations, the entire mitochondrial genome extracted from muscle was sequenced by direct DNA sequencing of the PCR product using a BigDye terminator cycle sequencing kit (Applied Biosystem, Foster City, CA, USA) and an ABI 3730XL (Applied Biosystem) automated sequencer. We applied the long PCR-based sequencing method to avoid nuclear pseudogene amplification.…”
Section: Mtdna Analysismentioning
confidence: 99%
“…18 For mutation analysis, first, the DNA samples were analyzed for the presence of large deletions and five common point mutations (A3243G, T3271C, A8344G, T8993G and T8993C) by southern blot/long-range PCR and PCR-restriction fragment-length polymorphism, respectively, according to published procedures. 15,19 Second, for those patients without common mutations, the entire mitochondrial genome extracted from muscle was sequenced by direct DNA sequencing of the PCR product using a BigDye terminator cycle sequencing kit (Applied Biosystem, Foster City, CA, USA) and an ABI 3730XL (Applied Biosystem) automated sequencer. We applied the long PCR-based sequencing method to avoid nuclear pseudogene amplification.…”
Section: Mtdna Analysismentioning
confidence: 99%
“…A mixture-template standard curve was used to revise the percentage of mutant mtDNA. We performed total mtDNA sequencing for selected cases, such as those with diffuse COX deficiency in their muscle biopsy, by the method previously described (Akanuma et al 2000).…”
Section: Introductionmentioning
confidence: 99%
“…No deleted band was amplified by long PCR (data not shown). Next, we sequenced the entire mtDNA of the patient as previously described [Akanuma et al, 2000].…”
Section: To the Editormentioning
confidence: 99%